SPG
60
2
CSX
57
-4
TROW
47
-6
KEY
43
-3
AA
56
15
PGR
59
-3
CAG
24
-3
AZO
50
-5
UAL
83
-2
YUM
43
-6
EFX
30
-8
BBY
52
6
VRSK
68
-12
RRC
52
-6
TRIP
50
-4
LRCX
37
-9
URI
60
-6
MRO
50
4
TGT
45
-4
TDC
67
-4
SPG
60
2
CSX
57
-4
TROW
47
-6
KEY
43
-3
AA
56
15
PGR
59
-3
CAG
24
-3
AZO
50
-5
UAL
83
-2
YUM
43
-6
EFX
30
-8
BBY
52
6
VRSK
68
-12
RRC
52
-6
TRIP
50
-4
LRCX
37
-9
URI
60
-6
MRO
50
4
TGT
45
-4
TDC
67
-4
Financhill
Back

DBV Technologies SA Vs. Akari Therapeutics PLC Industry Stock Comparison

Sell
31

DBVT
DBV Technologies SA

Last Price:
0.58
Seasonality Move:
-2.38%
Sell
22

AKTX
Akari Therapeutics PLC

Last Price:
2.01
Seasonality Move:
-8.33%
Sell
31
DBV Technologies SA (DBVT) is a Sell

Is DBV Technologies SA a Buy, Sell or Hold?

  • The current DBV Technologies SA [DBVT] share price is $0.59. The Score for DBVT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • DBVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $2.08. The Score for AKTX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DBVT Stock Price Chart

What is DBV Technologies SA's stock price today?

  • The DBV Technologies SA share price today is $0.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBVT is experiencing slight buying pressure.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $2.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

DBVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 34.55 Sell
Chaikin Money Flow: -2218 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.65 - 0.79) Sell
Bollinger Bands (100): (0.7 - 0.9) Sell

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 34.79 Sell
Chaikin Money Flow: 10527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.21 - 2.55) Sell
Bollinger Bands (100): (2.58 - 3.7) Sell

DBVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.66 Sell
20-day SMA: 0.73 Sell
50-day SMA: 0.72 Sell
200-day SMA: 1.11 Sell
8-day EMA: 0.65 Sell
20-day EMA: 0.7 Sell
50-day EMA: 0.74 Sell
200-day EMA: 1.14 Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.29 Sell
20-day SMA: 2.34 Sell
50-day SMA: 2.75 Sell
200-day SMA: 2.56 Sell
8-day EMA: 2.27 Sell
20-day EMA: 2.39 Sell
50-day EMA: 2.67 Sell
200-day EMA: 2.98 Sell

DBV Technologies SA Earnings Growth & DBVT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.19 per share.

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

DBV Technologies SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):